These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Effects of Nebivolol on left ventricular function and exercise capacity in patients with non-ischaemic dilated cardiomyopathy. A randomised placebo-controlled study. Patrianakos AP, Parthenakis FI, Mavrakis HE, Saatsaki M, Diakakis GF, Chlouverakis GI, Vardas PE. Hellenic J Cardiol; 2005; 46(3):199-207. PubMed ID: 15981555 [Abstract] [Full Text] [Related]
9. Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction. Rousseau MF, Chapelle F, Van Eyll C, Stoleru L, Hager D, Van Nueten L, Pouleur H. J Card Fail; 1996 Mar; 2(1):15-23. PubMed ID: 8798100 [Abstract] [Full Text] [Related]
13. Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS. Mulder BA, van Veldhuisen DJ, Crijns HJ, Böhm M, Cohen-Solal A, Babalis D, Roughton M, Flather MD, Coats AJ, Van Gelder IC. Eur J Heart Fail; 2012 Oct; 14(10):1171-8. PubMed ID: 22764183 [Abstract] [Full Text] [Related]
15. Influence of systolic blood pressure on clinical outcomes in elderly heart failure patients treated with nebivolol: data from the SENIORS trial. Montero-Perez-Barquero M, Flather M, Roughton M, Coats A, Böhm M, Van Veldhuisen DJ, Babalis D, Solal AC, Manzano L. Eur J Heart Fail; 2014 Sep; 16(9):1009-15. PubMed ID: 25044535 [Abstract] [Full Text] [Related]
16. Effects of nebivolol on biomarkers in elderly patients with heart failure. Taneja AK, Gaze D, Coats AJ, Dumitrascu D, Spinarova L, Collinson P, Roughton M, Flather MD, SENIORS Investigators. Int J Cardiol; 2014 Aug 01; 175(2):253-60. PubMed ID: 24877590 [Abstract] [Full Text] [Related]